Sandbox colesevelam: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{CMG}}; {{AE}} {{PB}} {{SB}} Fragmin injection ==Overview== '''Colesevelam''' is a bile acid sequestrant administered orally. It is developed by Genzyme ..." |
No edit summary |
||
| Line 20: | Line 20: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Bile Acid Sequestrant]] | |||
[[Cardiovasular Drugs]] | |||
[[Drugs]] | |||
Revision as of 20:56, 20 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
Synonyms / Brand Names: Fragmin injection
Overview
Colesevelam is a bile acid sequestrant administered orally. It is developed by Genzyme and marketed in the US by Daiichi Sankyo under the brand name Welchol and elsewhere by Genzyme as Cholestagel. In Canada it is marketed by Valeant as Lodalis.
Category
Bile Acid Sequestrant